SCHEMBL8218290

SCHEMBL8218290

COC(=O)C1C[C@@]1(C#N)c1ccc(Cl)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 1/20 0.41
SLC6A4 P31645 7/20 0.38
SLC6A3 Q01959 7/20 0.38
SLC6A2 P23975 5/20 0.38
CHRNA1 P02708 3/20 0.38
CHRNG P07510 3/20 0.38
ITGA5 P08648 3/20 0.38
CHRNB1 P11230 3/20 0.38
CHRNB2 P17787 3/20 0.38
CHRNB4 P30926 3/20 0.38
CHRNA3 P32297 3/20 0.38
CHRNA4 P43681 3/20 0.38
CHRND Q07001 3/20 0.38
MCL1 Q07820 1/20 0.35
ATM Q13315 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
PDE4A P27815 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE4C Q08493 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8215573 0.90 SLC6A4 (0.46) CCR2SLC6A4SLC6A3SLC6A2
SCHEMBL8218564 0.90 SLC6A4 (0.46) CCR2SLC6A4SLC6A3SLC6A2
SCHEMBL4728513 0.90 SLC6A4 (0.46) CCR2SLC6A4SLC6A3SLC6A2
SCHEMBL18346500 0.74 CCR2 (0.39) CCR2SLC6A4SLC6A3SLC6A2MCL1
SCHEMBL18346498 0.74 CCR2 (0.39) CCR2SLC6A4SLC6A3SLC6A2MCL1
SCHEMBL18346492 0.74 CCR2 (0.39) CCR2SLC6A4SLC6A3SLC6A2MCL1
SCHEMBL14255658 0.73 SLC6A3 (0.45) CCR2SLC6A4SLC6A3SLC6A2CYP3A4
SCHEMBL8216816 0.73 SLC6A3 (0.45) CCR2SLC6A4SLC6A3SLC6A2CYP3A4
SCHEMBL8208270 0.73 SLC6A3 (0.45) CCR2SLC6A4SLC6A3SLC6A2CYP3A4
SCHEMBL29302948 0.71 KDM4E (0.40) L3MBTL1SMN1; SMN2MAPTALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008013856-A2 METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1 ARYL -3-AZABICYCLO[3.1.0 ] HEXANES DOV PHARMACEUTICAL, INC. (US) 2008-01-31 WO disclosed